Policy & Regulation
Zymo Research partners with Tecan for viral COVID-19 RNA extraction
1 April 2020 -

Molecular biology tools company Zymo Research said on Tuesday that it plans to introduce its ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma and serum, in partnership with Tecan.

The DreamPrep NAP workstation, which features Zymo Research's Quick-DNA/RNA Viral MagBead Kit, provides pre-loaded scripts and optimized for viral RNA extraction, which are currently being validated for COVID-19 assays by high complexity testing labs.

Zymo's DreamPrep NAP workstation workflows require time-consuming scripting, configuration and optimization for the nucleic acid extraction to function properly, which can dramatically decrease lab scalability in this critical time.

In addition, the preprogrammed, preconfigured, load-and-go system is optimized for high-throughput viral RNA extraction. The workstation features a user-friendly interface and guided setup to streamline implementation, concluded the partnership.



Related Headlines